Annegret Dörfler Selected Research

isometronidazole

6/2004

Effect of the hypoxic cell sensitizer isometronidazole on local control of two human squamous cell carcinomas after fractionated irradiation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Annegret Dörfler Research Topics

Disease

7	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2010 - 02/2002
5	Neoplasms (Cancer) 01/2008 - 09/2003
2	Hypoxia (Hypoxemia) 09/2009 - 06/2004
2	Body Weight (Weight, Body) 05/2007 - 06/2005
1	Necrosis 06/2005

Drug/Important Bio-Agent (IBA)

2	Phosphotransferases (Kinase)IBA 09/2009 - 06/2005
2	Pharmaceutical PreparationsIBA 01/2008 - 05/2007
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2007 - 06/2005
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 06/2005 - 09/2003
2	vatalanib (PTK787)IBA 06/2005 - 09/2003
1	pimonidazoleIBA 07/2010
1	tyrosine receptor (receptor, tyrosine)IBA 09/2009
1	nintedanibIBA 09/2009
1	Lovastatin (Mevacor)FDA LinkGeneric 01/2008
1	BIBW 2669IBA 05/2007
1	AfatinibIBA 05/2007
1	Tyrosine Kinase InhibitorsIBA 05/2007
1	L 644711 (B-3(+))IBA 05/2007
1	Radiation-Sensitizing AgentsIBA 05/2007
1	Tyrosine (L-Tyrosine)FDA Link 06/2005
1	isometronidazoleIBA 06/2004
1	NitroimidazolesIBA 06/2004
1	AntibodiesIBA 02/2002

Therapy/Procedure

2	Radiotherapy 05/2007 - 06/2004
1	Transplantation 06/2005